National Research Corporation (NRC)

Etorro trading 970x250
National Research Corporation (NRC) Logo

About National Research Corporation

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska. Address: 1245 Q Street, Lincoln, NE, United States, 68508

National Research Corporation News and around…

Latest news about National Research Corporation (NRC) common stock and company :

National Research (NASDAQ:NRC) sheds 5.7% this week, as yearly returns fall more in line with earnings growth
05 Oct, 2021 Yahoo! Finance

It might be of some concern to shareholders to see the National Research Corporation ( NASDAQ:NRC ) share price down...

Calculating The Intrinsic Value Of National Research Corporation (NASDAQ:NRC)
30 Aug, 2021 Yahoo! Finance

How far off is National Research Corporation ( NASDAQ:NRC ) from its intrinsic value? Using the most recent financial...

National Research Corporation Declares Quarterly Dividend
20 Aug, 2021 FinancialContent
NRC Health Announces Winner of 2021 Excellence in Human Understanding Award
06 Aug, 2021 FinancialContent

Annual award honors Loma Linda UMC’s Stephanie Schwarzenbach for her outstanding commitment to patient care through the realm of Human Understanding

NRC Health Names Honorees of 2021 Excellence Awards
05 Aug, 2021 FinancialContent

Annual Awards Celebrate 12 Hospitals and Health Systems from Across the U.S. for Commitment to Delivering High Quality Patient Care

NRC Health Names Consumer Loyalty Award Winners at 27th Annual Symposium
05 Aug, 2021 FinancialContent

Fourth-Annual Awards Program Recognizes Top 100 U.S. Hospitals Leading in Patient Loyalty; Company Releases Mid-Year Trends Report Highlighting Evolving Consumer Sentiments on Pandemic-Induced Trends

National Research Corporation Announces Second Quarter 2021 Results
03 Aug, 2021 FinancialContent
National Research Corporation Announces Second Quarter 2021 Results
03 Aug, 2021 Yahoo! Finance

LINCOLN, Neb., Aug. 03, 2021 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced results for the second quarter of 2021. Financial Results (Q2 2021 compared to Q2 2020): Total Recurring Contract Value growth of 5% to $149.8 millionRevenue increased 17% to $36.4 millionOperating Income increased 32% to $12.2 million We saw significant improvement in revenue growth in the second quarter which is in line with our continued focus on increasing our revenue growth rate and e

Are Strong Financial Prospects The Force That Is Driving The Momentum In National Research Corporation's NASDAQ:NRC) Stock?
26 Jul, 2021 Yahoo! Finance

National Research (NASDAQ:NRC) has had a great run on the share market with its stock up by a significant 13% over the...

NRC Health’s Chief Security and Privacy Officer Recognized as One of the Top 100 CISOs in the Country
08 Jul, 2021 FinancialContent

Inaugural award from CISOs Connect honors Cris Ewell for his hard work and dedication to the cybersecurity community

National Research Corporation (NASDAQ:NRC) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
24 Jun, 2021 Yahoo! Finance

National Research Corporation ( NASDAQ:NRC ) stock is about to trade ex-dividend in four days. The ex-dividend date is...

Investors Shouldn't Overlook National Research's (NASDAQ:NRC) Impressive Returns On Capital
02 Jun, 2021 Yahoo! Finance

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

National Research Corporation Expands Board Strength with Appointments of Healthcare Industry Veterans
18 May, 2021 FinancialContent

Allina Health CEO Penny Wheeler and Former Sutter Health Chief Medical Officer Stephen Lockhart Add Their Deep Innovation and Vision to the Board

NRC Health Announces Top 10 Winners of the 2021 Customer Approved and Employee Approved Awards
10 May, 2021 FinancialContent

Leading senior living organizations honored for dedication and commitment to care amid the ongoing coronavirus pandemic

National Research Corporation Announces First Quarter 2021 Results
04 May, 2021 FinancialContent
If You Like EPS Growth Then Check Out National Research (NASDAQ:NRC) Before It's Too Late
03 May, 2021 Yahoo! Finance

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...

National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly
02 Apr, 2021 Yahoo! Finance

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

New Report from NRC Health Analyzes Healthcare Trends Through Pediatric Lens
31 Mar, 2021 FinancialContent

Study of Healthcare Consumers, Caregivers Reveals How COVID-19 Impacted Pediatric Population, Including Evolving Sentiments on Brand Loyalty, Telehealth, Digital Communication

Conestoga Capital Maintains National Research Corp. (NRC) Position Despite its Poor Returns
08 Mar, 2021 Yahoo! Finance

Conestoga Capital Advisors, a boutique, independent investment management firm, published its fourth-quarter 2020 ‘Small Cap Growth & SMid Cap Growth’ Investor Letter – a copy of which can be downloaded here. A net return of 31% was recorded by Conestoga’s Small Cap Growth fund and 19.72% return by its SMid Cap Growth Fund for the the […]

National Research (NASDAQ:NRC) Has Rewarded Shareholders With An Exceptional 304% Total Return On Their Investment
03 Mar, 2021 Yahoo! Finance

When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...

National Research (NRC) Shares Cross Above 200 DMA
24 Feb, 2021 FinancialContent

In trading on Wednesday, shares of National Research Corp (NRC) crossed above their 200 day moving average of $52.60, changing hands as high as $53.01 per share. National Research Corp shares are currently trading up about 2.4% on the day..

National Research Corporation Announces Fourth Quarter and Year-to-Date 2020 Results
09 Feb, 2021 FinancialContent
National Research Corporation Announces Fourth Quarter and Year-to-Date 2020 Results
09 Feb, 2021 Yahoo! Finance

LINCOLN, Neb., Feb. 09, 2021 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) (the “Company,” “we,” or “our”) today announced 2020 fourth quarter and year-end results. Fourth quarter 2020 compared to the fourth quarter 2019: Net New Sales decreased to $4.6 millionRevenue increased 7% to $34.8 millionOperating Income decreased 15% to $10.2 millionNet Income decreased 6% to $8.2 million 2020 calendar year results compared to 2019: Net New Sales increased to $28.1 millionTotal Recurring Contract Value increased 6% to $145.1 millionVoice of the Customer platform recurring contract value grew to $116.4 million, a 19% increaseRevenue increased 4% to $133.3 millionNet Income increased 15% to $37.3 million We continue to be inspired by the courageous efforts of our clients to provide care to their patients during the pandemic and are extremely proud of the work our associates are doing to support our clients. During a very challenging year, the strong demand for our Voice of the Customer (VoC) platform offerings in 2020 enabled our net new sales to increase over 2019 to $28.1 million. We believe our offerings are highly differentiated in our clients’ eyes against competitive offerings from firms outside of the healthcare industry and legacy vendors within. This differentiation drove the decision of several more of the nation’s largest and most prestigious healthcare systems to partner with NRC Health during 2020. We believe every added client deepens our moat and brings additive value to all current partners through the network effect as we continue our journey to enable human understanding. Total Recurring Contract Value increased by 6% at the end of the fourth quarter 2020 compared to the end of fourth quarter 2019, a subset of which is our VoC platform. Our VoC platform now comprises $116.4 million of Recurring Contract Value, an increase of 19% year-over-year. The increase in VoC platform revenue moved our overall revenue growth in a positive direction in the fourth quarter. We believe the efficiencies inherent in our digital platform have led to long-term margin improvements, a hallmark of our financial performance. At the same time, decisions supporting our distributed workforce environment, accelerated improvement in our VoC platform offerings and shift in our Canadian business resulted in additional expenses that contributed to a decrease in operating income margin in 2020. Following is additional information regarding our fourth quarter and year-end 2020 financial results. Fourth quarter 2020 revenue was $34.8 million, an increase of 7% over fourth quarter 2019. Consolidated operating income for the fourth quarter 2020 was $10.2 million or 29% of revenue, compared to $12.0 million or 37% of revenue for the same period last year. Total operating expenses of $24.6 million for the fourth quarter 2020 increased by 19% compared to the fourth quarter 2020 total operating expenses of $20.7 million. Incremental expenses of $957,000 related to the accelerated improvement of our VoC platform offerings were incurred in the fourth quarter. Fourth quarter operating expenses also included approximately $1.2 million in expense primarily due to the change in the estimated lives of certain assets related to our transformation to a distributed workforce environment, which includes building renovations in our headquarters, as well as shortening the useful lives of the right of use assets associated with the Atlanta, Georgia, and Markham, Ontario, office leases based on the expectation that we will vacate the office spaces before the end of the lease term. In addition, we recorded a goodwill impairment adjustment for the Canadian reporting unit of $714,000 to reflect a reduction in expected future cash flows from our Canadian business due to our decision to not renew a client agreement, which accounted for the majority of the revenue in Canada. The decision not to renew was based on our determination that the services under the terms of the agreement could not be migrated to our VoC platform in an economically viable manner. Total other expense decreased to $313,000 in the fourth quarter 2020 compared to $597,000 in the fourth quarter of 2019. This decrease in other net expense was primarily from a gain on insurance recoveries for property damages, decreased interest expense due to the declining balance on our Term Loan and no borrowings on our Line of Credit during the 2020 period and revaluation on intercompany transactions due to changes in the foreign exchange rate. The Company had an income tax provision of $1.7 million for fourth quarter 2020 compared to $2.7 million in 2019 with an effective tax rate of 17% for fourth quarter 2020 compared to 23% in 2019. This is primarily due to increased tax benefits of $1.0 million from the exercise and vesting of share-based compensation awards partially offset by a non-deductible goodwill impairment adjustment and higher state income taxes. Net income for fourth quarter 2020 was $8.2 million, compared to $8.7 million for the same period last year. Diluted earnings per share decreased to $0.32 for the quarter ended December 31, 2020, from diluted earnings per share of $0.34 for the quarter ended December 31, 2019. On a year-to-date basis, 2020 revenue increased by 4% to $133.3 million compared to $128.0 million in 2019. Operating income in 2020 decreased by 1%, from $43.0 million in 2019 to $42.7 million in 2020. Year-to-date net income for 2020 grew to $37.3 million, an increase of 15% over 2019 net income of $32.4 million. Net income growth in 2020 includes a decrease in the effective income tax rate from 20% in 2019 to 10% in 2020, primarily due to increased tax benefits from the exercise and vesting of share-based compensation awards. For more than 39 years, National Research Corporation has been a leading provider of analytics and insights that facilitate measurement and improvement of human understanding. This press release contains certain statements that may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such statements are subject to the safe harbor created by those sections and the Private Securities Litigation Reform Act of 1995, as amended. Such statements may be identified by their use of terms or phrases such as “believes,” derivations thereof, and similar terms and phrases. Forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, which could cause future events and actual results to differ materially from those set forth in, contemplated by, or underlying the forward-looking statements, including those risks and uncertainties as set forth in the Risk Factors section of our Annual Report on Form 10-K for the year ended December 31, 2019, our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, and various disclosures in our press releases, stockholder reports, and other filings with the Securities and Exchange Commission. In this press release, the statements relating to the future impact of adding additional clients are forward-looking statements. We disclaim any obligation to update or revise any forward-looking statements to reflect actual results or changes in the factors affecting the forward-looking information. NATIONAL RESEARCH CORPORATION AND SUBSIDIARY Unaudited Condensed Consolidated Statements of Income (In thousands, except per share data) Three months ended December 31, Twelve months ended December 31, 2020 2019 2020 2019 Revenue$ 34,774 $ 32,623 $ 133,277 $ 127,982Insurance recoveries -- -- 533 -- Operating expenses: Direct expenses 12,818 11,166 49,187 46,435Selling, general and administrative 8,887 8,241 34,441 32,973Depreciation, amortization and impairment 2,882 1,254 7,505 5,539Total operating expenses 24,587 20,661 91,133 84,947 Operating income 10,187 11,962 42,677 43,035 Other income (expense): Interest income 3 13 18 37Interest expense (447) (478) (1,813) (2,091)Other, net 131 (132) 585 (462) Total other expense (313) (597) (1,210) (2,516) Income before income taxes 9,874 11,365 41,467 40,519 Provision for income taxes 1,662 2,667 4,207 8,113 Net income$ 8,212 $ 8,698 $ 37,260 $ 32,406 Earnings Per Share of Common Stock: Basic Earnings Per Share$ 0.32 $ 0.35 $ 1.48 $ 1.30Diluted Earnings Per Share$ 0.32 $ 0.34 $ 1.45 $ 1.26 Weighted average shares and share equivalents outstanding Basic 25,337 24,852 25,170 24,809Diluted 25,684 25,715 25,696 25,653 NATIONAL RESEARCH CORPORATION AND SUBSIDIARY Unaudited Condensed Consolidated Balance Sheets (Dollars in thousands, except share amounts and par value) December 31, 2020 December 31, 2019 Assets Current assets: Cash and cash equivalents $34,690 $13,517 Accounts receivable, net 13,923 11,639 Income taxes receivable 1,235 69 Other current assets 4,264 3,932 Total current assets 54,112 29,157 Property and equipment, net 11,726 13,530 Goodwill 57,255 57,935 Other, net 10,330 10,063 Total assets $133,423 $110,685 Liabilities and Shareholders’ Equity Current liabilities: Current portion of notes payable $4,061 $4,378 Accounts payable and accrued expenses 4,279 4,687 Accrued compensation 6,460 6,086 Income taxes payable -- 366 Dividends payable -- 5,239 Deferred revenue 15,585 16,354 Other current liabilities 1,296 1,045 Total current liabilities 31,681 38,155 Notes payable, net of current portion 26,547 29,795 Other non-current liabilities 10,880 9,843 Total liabilities 69,108 77,793 Shareholders’ equity: Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued -- -- Common stock, $0.001 par value; authorized 60,000,000 shares, issued 30,775,154 in 2020 and 30,151,574 in 2019, outstanding 25,390,968 in 2020 and 24,947,500 in 2019 31 30 Additional paid-in capital 171,785 162,154 Retained earnings (accumulated deficit) (61,375) (93,357) Accumulated other comprehensive loss, foreign currency translation adjustment (2,399) (2,209)Treasury stock (43,727) (33,726)Total shareholders’ equity 64,315 32,892 Total liabilities and shareholders’ equity $133,423 $110,685 Contact:Kevin R. Karas Chief Financial Officer 402-475-2525

Earnings Scheduled For February 9, 2021
09 Feb, 2021 FinancialContent

Companies Reporting Before The Bell • Camtek (NASDAQ:CAMT) is projected to report quarterly earnings at $0.19 per ...

NRC Health Examines How COVID-19 Reshaped Healthcare Consumerism in New Report
13 Jan, 2021 FinancialContent
The Best Comeback Stocks to Buy in 2021
30 Dec, 2020 FinancialContent

The vaccine is here, but it is going to take time to get widely distributed.

NRC Health Awards Annual Scholarship to UNL Students
05 Nov, 2020 FinancialContent

NRC Health awards Rising Stars Scholarship to successful business students.

National Research Corporation Announces Third Quarter and Year-to-Date 2020 Results
03 Nov, 2020 FinancialContent

Net New Sales and Total Contract Value Continue Impressive Growth

National Research Corporation (NRC) is a NASDAQ Common Stock listed in , ,

970x250